EyePoint Pharmaceuticals Inc.

NAS: EYPT

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2022, 1:56 p.m.

/zigman2/quotes/210537129/composite

$

7.35

Change

-0.30 -3.92%

Volume

Volume 24,522

Real time quotes

/zigman2/quotes/210537129/composite

Previous close

$ 7.65

$ 7.35

Change

-0.30 -3.92%

Day low

Day high

$7.31

$7.65

Open

52 week low

52 week high

$6.91

$21.50

Open

Nancy Sue Lurker

Transactions

Date Shares Transaction Value
06/30/2020 124,667   Derivative/Non-derivative trans. at $0 per share. 0
06/27/2020 40,000   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2020 45,000   Derivative/Non-derivative trans. at $0 per share. 0
03/10/2020 98,000   Acquisition at $1.06 per share. 103,880
02/21/2020 137,174   Derivative/Non-derivative trans. at $0 per share. 0
10/12/2019 10,745   Derivative/Non-derivative trans. at $2.1 per share. 22,565
06/27/2019 40,000   Derivative/Non-derivative trans. at $0 per share. 0
06/14/2019 45,000   Derivative/Non-derivative trans. at $0 per share. 0
03/29/2019 28,500   Acquisition at $1.76 per share. 50,160
10/12/2018 76,667   Award at $0 per share. 0
06/27/2018 40,000   Derivative/Non-derivative trans. at $0 per share. 0
03/19/2018 38,333   Award at $0 per share. 0

Officers and Executives

Dr. Jay S. Duker
Chief Operating Officer
Mr. George O. Elston
CFO & Head-Corporate Development
Dr. Said Saim
Chief Technology Officer
Dr. Dario A. Paggiarino
Chief Medical Officer & Senior Vice President
Ms. Jennifer Leonard
Chief People Officer & Senior Vice President-IT
Mr. Scott Jones
Chief Commercial Officer & Senior Vice President
Mr. Michael C. Pine
Chief Corporate Development & Strategy Officer
Mr. Ye Liu
Director
Dr. Anthony P. Adamis
Director
Ms. Karen L. Zaderej
Director
Mr. Ron I. Honig
Secretary, Chief Legal Officer & Senior VP
Ms. Isabelle Lefebvre
Chief Regulatory Officer
Dr. Göran Albert Torstensson Ando
Non-Executive Chairman
Ms. Wendy F. DiCicco
Independent Director
Dr. John Barry Landis
Independent Director
Dr. David R. Guyer
Independent Director
Link to MarketWatch's Slice.